Maryland Heights, MO, April 28, 2017 --(PR.com
)-- Multiplexed molecular diagnostics involves analyzing large number of target analytes present in biochemical substances, cells of an organism, or an organic sample for disease diagnosis, quantitatively as well as qualitatively. Multiplexed diagnostics assays are preferred over single plex assays considering its low cost, high throughout nature and less turnaround time. Multiplexed assays are also used in drug discovery and phases of clinical development in pharmaceutical industries, scientific research and genomic screening. Automation, technological advancement, widespread availability, and higher prevalence of cancer and infectious diseases has driven the growth of global multiplexed diagnostics market.
Browse Multiplex Molecular Diagnostics Market by Technology (Low Density Assays – Quantitative PCR, Microplate Assays, Medium Density Assays - Bead-based Arrays, Antibody Arrays, Reverse Arrays, Mass Spectrometry, High Density Assays - Bacterial Artificial Chromosome Arrays, Protein Arrays, Very High Density Assays - Oligonucleotide Arrays, Second Generation Sequencing, Phage Display), Application (Allergies, Autoimmune Diseases, Cardiac Diseases, Infectious Disease Diagnostics, Oncology, Pregnancy & Fertility Testing), End Users (Academic Research Institutes, Clinical Research Organizations, Diagnostic Laboratories, Hospital, Pharmaceutical Companies) and Forecast 2017-2021 report at https://www.ihealthcareanalyst.com/report/multiplex-molecular-diagnostics-market/
The global multiplexed molecular diagnostics market segmentation is based on technology (low density multiplexed assays, microplate assays, quantitative PCR, medium density multiplexed assays, antibody arrays, bead-based arrays, mass spectrometry, reverse arrays, high density multiplexed assays, bacterial artificial chromosome arrays, protein arrays, very high density multiplexed assays, oligonucleotide arrays, phage display, next generation sequencing assays), and applications (allergies, autoimmune diseases, cardiac disorders, infectious disease diagnosis, oncology).
The global multiplexed molecular diagnostics market report provides market size (Revenue USD Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021). The global multiplexed molecular diagnostics market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market and provides analysis of the company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market. The global multiplexed molecular diagnostics market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global multiplexed molecular diagnostics market and included in this report are Affymetrix, Agilent Technologies, Gen-Probe, Inc., bioMerieux, Luminex Corporation, Illumina, Inc. and Life Technologies (Thermo Fisher Scientific).
1.1. Low Density Assays (plex ≤ 5)
1.1.1. Quantitative PCR
1.1.2. Microplate Assays
1.2. Medium Density Assays (plex < 500)
1.2.1. Bead-based Arrays
1.2.2. Antibody Arrays
1.2.3. Reverse Arrays
1.2.4. Mass Spectrometry
1.3. High Density Assays (500 ≤ plex ≤ 10,000)
1.3.1. Bacterial Artificial Chromosome Arrays
1.3.2. Protein Arrays
1.4. Very High Density Assays (> 10,000-plex)
1.4.1. Oligonucleotide Arrays
1.4.2. Second Generation Sequencing
1.4.3. Phage Display
2.2. Autoimmune Diseases
2.3. Cardiac Diseases
2.4. Infectious Disease Diagnostic
2.6. Pregnancy & Fertility Testing
3. End Users
3.1. Academic Research Institutes
3.2. Clinical Research Organizations
3.3. Diagnostic Laboratories
3.5. Pharmaceutical Companies
4. Geography (Region, Country)
4.1. North America (U.S., Canada)
4.2. Latin America (Brazil, Mexico, Rest of LA)
4.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
4.4. Asia Pacific (Japan, China, India, Rest of APAC)
4.5. Rest of the World
5. Company Profiles
5.1. Abbott Laboratories
5.2. Agilent Technologies
5.3. bioMérieux SA
5.4. Bio-Rad Laboratories, Inc.
5.5. F. Hoffmann-La Roche Ltd.
5.6. Hologic, Inc.
5.7. Illumina, Inc.
5.8. Luminex Corporation
5.9. Siemens Healthineers
5.10. Thermo Fisher Scientific, Inc.
To request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/report/multiplex-molecular-diagnostics-market/
iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043